Breaking News

Eurofins, UK SBS in Genomics Supply Pact

May 15, 2014

Two-year contract covers oligonucleotides and DNA sequencing services

UK Shared Business Services Ltd. (UK SBS) has selected Eurofins Genomics as preferred supplier for oligonucleotides and DNA sequencing services.
 The two-year contract builds on the companies seven-year relationship developed by the seven research councils of the UK, which was established to provide centralized services to the research councils and their institutes with the goal of reducing costs and improving operational efficiency.
 
"We are delighted to have been selected as one of the preferred suppliers for both oligonucleotides and DNA sequencing by RCUK based upon our product quality and the level of service provided," said Bruno Poddevin, senior vice president Eurofins Genomics "This contract will ensure that the whole UK SBS scientist community will have full access to the Eurofins Genomics' products and services and benefit from our continued commitment to them."


 
Tony Nwagbolu, category manager, Genomics at UK SBS said, "Eurofins has become a true strategic partner of UK SBS whose commercial expertise and efficient operational models supports the alignment of our key stakeholders operations and development of our business objectives - reducing cost, enhancing service and delivering value for taxpayers."
 
blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.